Catalpol ameliorates intervertebral disc degeneration by suppressing NP cell Pyroptosis via the NF-ĸB pathway
International Immunopharmacology · 2026-10 · 186 · 117118
DOI: 10.1016/j.intimp.2026.117118 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Chenhua Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine School of Clinical Medicine, Jiangxi, Nanchang 330004, China. Hauptthemen laut MEDLINE: Iridoid Glucosides, Pyroptosis, Intervertebral Disc Degeneration, Nucleus Pulposus. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Intervertebral disc degeneration (IDD) is a prevalent degenerative disorder and a leading cause of low back pain. Catalpol (CAT) possesses recognized anti-inflammatory and antioxidant properties and shows therapeutic potential for various inflammatory diseases; however, its role in IDD remains unclear. This study aimed to investigate the protective effects of CAT against IDD and to elucidate its underlying mechanism. The study employed both in vitro and in vivo experimental models. The effects of CAT on IDD progression were assessed, with a focus on nucleus pulposus (NP) cell pyroptosis. Mechanistic investigations were conducted to examine the involvement of the NF-κB/NLRP3-mediated pyroptotic pathway, including the nuclear translocation of phosphorylated P65 (p-P65). The dependence of CAT's action on this pathway was further verified through P65 overexpression experiments. CAT was demonstrated to alleviate IDD in experimental models. It exerted its protective effect by inhibiting pyroptosis in NP cells. Mechanistically, CAT blocked the nuclear translocation of p-P65, thereby suppressing the NF-κB/NLRP3-mediated pyroptotic pathway. The reversal of CAT's protective effects upon P65 overexpression confirmed that its action is dependent on this pathway. This study reveals that CAT alleviates IDD by directly targeting P65 to inhibit NP cell pyroptosis via the NF-κB/NLRP3 pathway. These findings identify CAT as a novel therapeutic candidate and provide a mechanistic insight for the treatment of intervertebral disc degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine School of Clinical Medicine, Jiangxi, Nanchang 330004, China.
- Affiliated Hospital of Jiangxi University of traditional Chinese Medicine, Jiangxi, Nanchang 330006, China.
- Gao'an Hospital of Traditional Chinese Medicine, Gao'an, Jiangxi, China.
- Department of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
- Department of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China. Electronic address: 2003…
- Department of Traumatology and Orthopedics, Lishui People's Hospital, Lishui, Zhejiang 323000, China; Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine School of Clinical Medicine, Jiangxi,…
Zitieren
APA
Wang, C., Liang, W., Yang, F., Zhu, P., Cui, Y., Lu, Y., Yang, W., Ji, W., & Yu, G. (2026). Catalpol ameliorates intervertebral disc degeneration by suppressing NP cell Pyroptosis via the NF-ĸB pathway. International Immunopharmacology, 186, 117118. https://doi.org/10.1016/j.intimp.2026.117118
Vancouver
Wang C, Liang W, Yang F, Zhu P, Cui Y, Lu Y, et al. Catalpol ameliorates intervertebral disc degeneration by suppressing NP cell Pyroptosis via the NF-ĸB pathway. International Immunopharmacology. 2026;186:117118. doi:10.1016/j.intimp.2026.117118
BibTeX
@article{Wang2026,
author = {Wang, Chenhua and Liang, Weidong and Yang, Fengyun and Zhu, Peng and Cui, Yubo and Lu, Yizhong and Yang, Wenlong and Ji, Weifeng and Yu, Guisong},
title = {Catalpol ameliorates intervertebral disc degeneration by suppressing NP cell Pyroptosis via the NF-ĸB pathway},
journal = {International Immunopharmacology},
year = {2026},
volume = {186},
pages = {117118},
doi = {10.1016/j.intimp.2026.117118}
}
EUVIMED